LOX-1 activation induces endothelial dysfunction by mechanisms involving NF-κB activation, oxidative stress, and reduction in NO levels (reviewed in [57]), similar to the ones described for PE STBEVs in the present study. The gene discussed is NFKB1; the disease is endothelial dysfunction.